Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosis.

Toledo MAS, Gatz M, Sontag S, Gleixner KV, Eisenwort G, Feldberg K, Hamouda AEI, Kluge F, Guareschi R, Rossetti G, Sechi AS, Dufva OMJ, Mustjoki SM, Maurer A, Schuler HM, Goetzke R, Braunschweig T, Kaiser A, Panse J, Jawhar M, Reiter A, Hilberg F, Ettmayer P, Wagner W, Koschmieder S, Brummendorf TH, Valent P, Chatain N, Zenke M
Blood. 2021 Apr 15;137(15):2070-2084. doi: 10.1182/blood.2019004509. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.